Perrigo Beats Reckitt Unit’s Suit Over Generic Mucinex

Law360, New York (January 11, 2012, 7:11 PM EST) -- A Michigan federal judge on Wednesday shut down a Reckitt Benckiser Inc. unit's suit accusing Perrigo Co. of patent infringement in its attempts to market a generic version of the company's Mucinex respiratory relief drug.

U.S. District Judge Gordon J. Quist granted Perrigo's motion for summary judgment, finding that the precedent established in the Federal Circuit's ruling last year in which it shut down a similar case waged by Reckitt against Watson Laboratories Inc. mandated that the case against Perrigo be similarly dispensed with.

Given that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.